Valiant Laboratories Limited

₹113.78As of Sun 8 Nov 2026, 12:00 UTC
NSE:VALIANTLABHealthcare
Country India
PE (Fwd) •••
TSR 3Y CAGR (13.51%)
Div yield —
ROE 5.00%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.81
PE TTM 35.24
TSR TTM 37.52%
Mkt cap ₹6.180B
ROIC 5.34%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹142
24.37%
(65.01%)
Hold 6|1|12|1|8
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
2.16
2.09
2.30
2.34
(1.45%)
(0.89%)
3.88%
7.54%
Revenue₹M
432.2
437.4
447.8
459.5
10.61%
7.19%
4.89%
4.12%
Peers (US$67.15M)
Cap (US$)
PE
74.98M
326.5x
74.06M
14.35x
Capital
TTM
5Y
10Y
Leveragex
4.268
2.906
2.557
EBIT/Intx
0.597
2.252
1.839
Own earn%
(47.62)
120.18
118.34
Sh yield%
32.26
31.89
30.03
Owners
Insiders/Inst%
10.71
79.38
Short interest%
0.86
SBC / revenue%
5.99
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
24–31
$1 testx
0.4
Incr. ROIC%
3